Technical Analysis for BTI - biOasis Technologies Inc.

Grade Last Price % Change Price Change
F 0.005 0.00% 0.000
BTI closed unchanged on Thursday, November 21, 2024, on 17 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

biOasis Technologies Inc. Description

biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Transport Medicine Pharma Pharmaceutical Delivery Disease Biology Biopharmaceutical Diseases Disorders Alzheimer's Disease Neurological Diseases Neurology Biomarker Brain Central Nervous System Nervous System

Is BTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.29
52 Week Low 0.005
Average Volume 132,597
200-Day Moving Average 0.424
50-Day Moving Average 0.713
20-Day Moving Average 0.130
10-Day Moving Average 0.130
Average True Range 0.207
RSI (14) 44.13
ADX 21.55
+DI 43.867
-DI 54.873
Chandelier Exit (Long, 3 ATRs) 0.648
Chandelier Exit (Short, 3 ATRs) 0.627
Upper Bollinger Bands 0.880
Lower Bollinger Band -0.620
Percent B (%b) 0.42
BandWidth 1153.846
MACD Line -0.205
MACD Signal Line -0.213
MACD Histogram 0.0085
Fundamentals Value
Market Cap 339.82 Thousand
Num Shares 68 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 5.40
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.005
Resistance 3 (R3) 0.005 0.005 0.005
Resistance 2 (R2) 0.005 0.005 0.005 0.005
Resistance 1 (R1) 0.005 0.005 0.005 0.005 0.005
Pivot Point 0.005 0.005 0.005 0.005 0.005
Support 1 (S1) 0.005 0.005 0.005 0.005 0.005
Support 2 (S2) 0.005 0.005 0.005 0.005
Support 3 (S3) 0.005 0.005 0.005
Support 4 (S4) 0.005